增持方面，新集能源公告称，截至9月末控股股东中国中煤持股比例由30.31%增至31.72%，目前增持计 划正在实施中。 更多央企将市值管理纳入系统性工程。中国石化集团近期启动"中国石化上市公司市值提升专项行动"， 着力提升投资价值，增强股东回报；大秦铁路、招商南油等公司陆续制定并实施市值管理制度和股份回 购方案，以真金白银向市场传递发展信心。 国资委数据显示，目前，央企控股上市公司市值超过22万亿元，较"十三五"末增长了近50%，"十四 五"以来，累计实施现金分红2.5万亿元，成为维护资本市场平稳运行的重要力量。 ● 本报记者 刘丽靓 日前召开的中央企业负责人会议明确，2026年要加强上市公司质量和市值管理。这一表态恰逢国资委 《关于改进和加强中央企业控股上市公司市值管理工作的若干意见》印发满一年之际。 一年来，在政策持续催化下，央企市值管理正加速从监管要求转化为企业的系统性行动与真金白银的市 场承诺。业内人士认为，随着制度体系不断完善，回购增持等举措密集落地，市值管理已日益成为衡量 国企改革成效、提升国有资本效能、稳定资本市场预期的重要综合尺度，以提升价值创造能力为核心的 国企改革新图景正加速铺展。 央企市 ...

瞄准广州打造世界级汽车产业集群的目标，广州国资正加速新能源汽车产业链整合。 公开资料显示，旭升集团成立于2003年，主营精密铝合金零部件，产品广泛应用于新能源汽车、储能与 机器人等领域。公司是目前业内少数同时掌握压铸、锻造、挤压三大工艺并具备集成化生产能力的企 业，尤其在新能源轻量化领域具有领先地位。公司也在储能领域与机器人迅速拓展业务，比如聚焦关节 壳体、躯干结构件等核心零部件，与多家头部机器人企业建立深度合作。 这与广州工控的业务方向高度契合。广州工控集团正加快产业链垂直整合，聚焦新能源汽车、智能装备 等新质生产力赛道，通过"大龙头-大项目-大集群"模式，构建千亿级先进制造业产业集群。同时，广州 工控正加快构建覆盖核心零部件、整机研发、系统集成与海外应用的具身智能全产业链生态。 旭升集团在12月22日晚关于控股股东、实际控制人及其一致行动人签署《控制权收购协议》《股份转让 协议》暨控制权拟发生变更的提示性公告中也提到，本次权益变动的目的是广州工控集团为了贯彻落实 《关于深化国有企业改革的指导意见》及其配套文件精神，深入推进国有企业改革，完善广州工控集团 在新能源汽车领域的全链条布局。 近日，旭升集团（60 ...

证券之星消息，12月26日江苏国企改革板块较上一交易日上涨0.68%，苏州高新领涨。当日上证指数报 收于3963.68，上涨0.1%。深证成指报收于13603.89，上涨0.54%。江苏国企改革板块个股涨跌见下表： 从资金流向上来看，当日江苏国企改革板块主力资金净流出3.68亿元，游资资金净流入1.05亿元，散户 资金净流入2.63亿元。江苏国企改革板块个股资金流向见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

格隆汇12月26日丨粤高速Ａ(000429.SZ)公布，为深入实施国企改革深化提升行动对推进战略性重组和 专业化整合的要求，更大力度布局前瞻性战略性新兴产业，现拟将公司所持赣州康大高速公路有限责任 公司（下称"康大公司"）30%股权和广东省粤普小额再贷款股份有限公司（下称"粤普再贷"）15.48%股 权无偿划转至公司的全资子公司粤高资本控股（广州）有限公司（下称"粤高资本"）。本次股权无偿划 转事项属于公司与全资子公司之间的内部划转，不构成关联交易，不构成《上市公司重大资产重组管理 办法》规定的重大资产重组。 ...

Core Viewpoint - 弘业期货 is a significant player in the futures market, with a focus on various financial services, and has recently experienced a decline in revenue and profit margins [2][7]. Company Overview - 弘业期货股份有限公司 primarily engages in commodity futures brokerage, financial futures brokerage, futures investment consulting, asset management, fund sales, and financial asset investment [2][7]. - The company is the first A+H share listed company in the futures industry and is controlled by the Jiangsu Provincial Government's State-owned Assets Supervision and Administration Commission [3][7]. - As of September 30, 2025, 弘业期货 reported a revenue of 462 million yuan, a year-on-year decrease of 76.77%, and a net profit attributable to shareholders of 2.09 million yuan, down 87.27% year-on-year [7]. Financial Performance - The company has a market capitalization of 10.703 billion yuan and a trading volume of 115 million yuan with a turnover rate of 1.42% [1]. - The average trading cost of the stock is 11.30 yuan, with the current stock price near a resistance level of 10.69 yuan, indicating potential for upward movement if the resistance is broken [6]. - The company has distributed a total of 44.3422 million yuan in dividends since its A-share listing [8]. Shareholder Structure - As of September 30, 2025, the number of shareholders is 54,400, a decrease of 13.10% from the previous period [7]. - Major shareholders include Hong Kong Central Clearing Limited and Southern CSI 1000 ETF, with notable reductions in their holdings [8].

Core Viewpoint - The company, Zhonghong Medical, is experiencing fluctuations in stock performance and is focusing on innovation in medical devices, particularly in radiation protection gloves and veterinary infusion pumps, while benefiting from the depreciation of the RMB. Group 1: Company Performance - On December 26, Zhonghong Medical's stock fell by 0.93%, with a trading volume of 45.25 million yuan and a market capitalization of 5.498 billion yuan [1] - As of September 30, the company reported a revenue of 1.864 billion yuan for the first nine months of 2025, representing a year-on-year growth of 1.38%, while the net profit attributable to shareholders was -7.21 million yuan, a decrease of 114.13% year-on-year [9] - The company has distributed a total of 1.251 billion yuan in dividends since its A-share listing, with 501 million yuan distributed over the past three years [10] Group 2: Business Operations - Zhonghong Medical specializes in the research, production, and sales of high-quality nitrile gloves and PVC gloves, with a revenue composition of 89.48% from health protection products, 6.22% from safety infusion products, and 4.30% from innovative incubation products [8] - The company operates primarily through ODM direct sales, producing medical devices and consumables for overseas brand owners [3] - As of the 2024 annual report, overseas revenue accounted for 81.56% of total revenue, benefiting from the depreciation of the RMB [4] Group 3: Product Innovation - The company is collaborating with Guilin University of Technology to develop a multi-layer radiation protection glove, which includes a chemical protection layer, a white warning layer, and a nuclear radiation protection layer [2] - At the 12th Beijing Pet Expo, Zhonghong Medical showcased its veterinary infusion pumps, which feature IP34 waterproof design and dual CPU architecture, providing various infusion modes and safety features [2]

Core Viewpoint - The company, Chongqing Port, is experiencing fluctuations in its stock performance, with a recent increase in stock price and a focus on its core logistics and port operations amidst various strategic initiatives [1][4]. Group 1: Company Overview - Chongqing Port specializes in port transshipment and comprehensive logistics services, including loading and unloading, cargo agency, and trade [2][3]. - The company has developed specialized terminals for containers, general cargo, and chemicals, leading to its position as the top port in Southwest China in terms of cargo throughput [2]. - As a state-owned enterprise, Chongqing Port is controlled by the Chongqing State-owned Assets Supervision and Administration Commission [3]. Group 2: Strategic Positioning - The company is strategically located at key national initiatives such as the "Belt and Road" and the Yangtze River Economic Belt, serving as a crucial hub for connectivity [3]. - Chongqing Port integrates various logistics elements, including warehousing, shipping, and multi-modal transport, to enhance its trade logistics and supply chain logistics capabilities [2]. Group 3: Financial Performance - For the period from January to September 2025, Chongqing Port reported a revenue of 3.281 billion yuan, a year-on-year decrease of 5.10%, and a net profit attributable to shareholders of 48.1743 million yuan, down 35.43% year-on-year [7]. - The company has distributed a total of 799 million yuan in dividends since its A-share listing, with 148 million yuan distributed over the past three years [8]. Group 4: Market Activity - The stock experienced a trading volume of 5.91 billion yuan with a turnover rate of 8.29%, and the total market capitalization reached 6.943 billion yuan [1]. - Recent net inflows from major investors were negative, indicating a lack of clear upward momentum in the stock [4][5].

光大证券发布研报称，中石化炼化工程(02386)收购集团下属华东管道设计院资产，有助于公司扩充在 管道储运领域的业务资质，进一步增强公司整体竞争力。该行维持对公司的盈利预测，预计公司2025- 2027年归母净利润分别为25.95、27.60、29.02亿元，对应的EPS分别为0.59、0.63、0.66元/股。公司背靠 中石化集团资源优势，持续开拓海内外市场，业绩有望持续增长，国企改革背景下公司低估值+高分红 价值凸显，该行维持对公司的"买入"评级。 光大证券主要观点如下： 公司加快国内外市场拓展，新签合同额快速增长，2025年前三季度，公司新签合同额为913亿元，同比 增长24.4%，其中，国内新签合同545亿元，同比增长16.3%，海外新签合同369亿元，同比增长38.6%。 截至2025年9月，公司未完成合同额为2155亿元，同比增长24.8%。展望未来，中国现代化产业体系正 加快构建，石化行业高质量发展扎实推进，石化下游产业链不断延伸，高端新材料项目资本开支保持增 长;中东地区活跃资本开支已超千亿美元，产油国炼化生产能力逐年提升。中国石化集团深化"一带一 路"合作，公司充分受益于平台优势，中东市场订 ...

会议明确指出，要"因地制宜"推动发展，其中涉及企业的相关内容，为国资央企下一步的改革与发展指 明了方向。 深入理解并践行这一要求，不仅是国企避免踏入不必要误区的基础，更是激发 责编|亿亿 编辑|阿苓 知风云：近年来，国企改革持续向纵深推进，在取得显著成效的同时，也面临新的挑战与课题。在最新 召开的经济工作会议上，"因地制宜"被专门提出并强调，成为指导经济发展的重要原则之一。 作者|知本咨询国企投资与运营研究院 ...

Investment Rating - The report maintains a "Buy" rating for Sinopec Engineering (2386.HK) [4][6] Core Insights - The acquisition of East China Pipeline Design Institute enhances the company's pipeline transportation business qualifications, expected to improve overall competitiveness [2] - The company has seen rapid growth in new contracts, with a total of 913 billion yuan signed in the first three quarters of 2025, representing a year-on-year increase of 24.4% [3] - The company is well-positioned to benefit from the modernization of China's industrial system and the high-quality development of the petrochemical industry, particularly in the Middle East market [3] Summary by Sections Acquisition and Business Expansion - The company announced the acquisition of 100% equity in East China Pipeline Design Institute for 191 million yuan, which will strengthen its integrated EPC service capabilities from design to procurement and construction [1][2] - The East China Pipeline Design Institute, established in 1993, has a projected net profit of 10.48 million yuan for 2024 and a net asset value of 168 million yuan as of August 31, 2025 [2] Market Growth and Contract Acquisition - The company has accelerated its market expansion, achieving a 24.4% year-on-year increase in new contracts, with domestic contracts growing by 16.3% and overseas contracts by 38.6% [3] - The total uncompleted contract amount reached 2,155 billion yuan, a 24.8% increase year-on-year, indicating strong future revenue potential [3] Financial Forecast and Valuation - The report forecasts net profits for 2025-2027 to be 2.595 billion, 2.760 billion, and 2.902 billion yuan respectively, with corresponding EPS of 0.59, 0.63, and 0.66 yuan per share [4] - The company is expected to maintain a low valuation with high dividend value, supported by its resource advantages from Sinopec Group [4]